This Orally Disintegrating Tablet (ODT) Market is Likely to Experience a Tremendous Growth by 2029 research report focuses more on a number of distinctive as well as foremost market sectors.
Orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period. According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second.
The major factor for the growth of the global orally disintegrating tablet (ODT) market during the forecast period is the increasing demand for these tablets due to ease of use and new product launches.
For instance, in February 2022, Dr Reddy’s Laboratories Ltd. along with its subsidiaries announced the launch of Lansoprazole DR Orally Disintegrating Tablets.
These tablets are a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, which is approved by the US FDA. Additionally, in July 2021, SPI Pharma launched UltraBurst an orally disintegrating tablet (ODT).
Ultrabrust is an innovative excipient platform for flash ODTs, which disintegrate in under ten seconds. Furthermore, in December 2021, Edenbridge Pharmaceuticals, LLC announced the approval of its New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets from the US FDA.
DARTISLA ODT is an orally disintegrating tablet available in 1.7 mg for the treatment of peptic ulcers in adults.
Some major players in the market include Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.
For instance, in November 2021, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the US.
Rimegepant is commercialized as Nurtec ODT in the US and is used for the treatment of episodic migraine in adults.
To Request a Sample of our Report on Orally Disintegrating Tablet (ODT) Market: www.omrglobal.com/request…odt-market
Market Coverage
- • The market number available for – 2022-2030
- • Base year- 2022
- • Forecast period- 2022-2030
- • Segment Covered-
- By Drug Class
- By Disease Indication
- By Distribution Channel
- • Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others.
A full Report Orally Disintegrating Tablet (ODT) Market is Available @ www.omrglobal.com/industr…odt-market
Orally Disintegrating Tablet (ODT) Market Report by Segment
By Drug Class
- • Anti-Psychotics
- • Anti-Epileptics
- • CNS Stimulants
- • Anxiolytics
- • Anti-Parkinsonian Drugs
- • NSAIDS
- • Anti-Allergy Drugs
- • Others
By Disease Indication
- • CNS Diseases
- • GI Diseases
- • CVS Disorders
- • Allergy
- • Others
By Distribution Channel
- • Hospital Pharmacies
- • Retail Pharmacies
- • Drug Stores
- • Online Pharmacies
Orally Disintegrating Tablet (ODT) Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to access this report
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
News From
Orion Market Research Pvt. Ltd.Category: Market Research Publishers and Retailers Profile: Orion Market Research (OMR) is a market research company that endeavors to provide an exclusive blend of qualitative and quantitative market research reports to global clients. The company provides syndicate, customized market research report for over 20 business domains to customers across the globe. These reports provide valuable market insights to global clients in understanding the market trends and taking crucial business decisions. The company is serving global Fortune 500 companies, ...
For more information:
